{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:26:18Z","timestamp":1787253978652,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ministry of Health, Labor and Welfare, Japan","award":["23AA2003"],"award-info":[{"award-number":["23AA2003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Denosumab, a well-established osteoporosis treatment, has demonstrated potential bone- and cartilage-protective effects in preclinical and early trials. However, it remains unclear whether these promising findings extend to osteoarthritis prevention in weight-bearing joints and broader real-world osteoporotic populations. We compared osteoarthritis incidence between denosumab and oral bisphosphonates in adults aged 50\u00a0yr or older with osteoporosis using a sequential nested target trial emulation with propensity score matching based on longitudinal health insurance claims data from Japan collected between 2015 and 2024. Two target comparisons were conducted: one compared new users of denosumab with new users of oral bisphosphonates, and the other compared patients who switched from oral bisphosphonates to denosumab with those who continued oral bisphosphonates. The primary outcome was osteoarthritis incidence. Secondary outcomes included joint-specific osteoarthritis (knee, hip, and hand) over 3\u00a0yr. The absolute risk reduction (ARR) and relative risk (RR) at 3\u00a0yr were estimated using a Kaplan\u2013Meier estimator in both the per-protocol and intention-to-treat (ITT) analyses. In the per-protocol analyses, the ARR for incident osteoarthritis was 2.0% (95% CI, 1.1%-3.2%) in the new-user comparison, with an RR of 0.83 (95% CI, 0.73-0.91), and 0.9% (95% CI, \u22120.2% to 2.8%) in the switch-continue comparison, with an RR of 0.92 (95% CI, 0.76-1.02). In the ITT analyses, the corresponding ARR was 1.9% (95% CI, 1.3%-3.3%) in the new-user comparison, with an RR of 0.84 (95% CI, 0.73-0.89), and 1.2% (95% CI, \u22120.2% to 2.7%) in the switch-continue comparison, with an RR of 0.89 (95% CI, 0.77-1.02). Denosumab initiation was associated with a modestly lower risk of incident osteoarthritis than oral bisphosphonate initiation, although the association was weaker in the switch-continue comparison.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag113","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:02:21Z","timestamp":1784721741000},"source":"Crossref","is-referenced-by-count":0,"title":["Osteoarthritis risk associated with denosumab in adults with osteoporosis: a target trial emulation"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-5604","authenticated-orcid":false,"given":"Masaki","family":"Hatano","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-0596","authenticated-orcid":false,"given":"Yuya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Graduate School of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6480-3388","authenticated-orcid":false,"given":"Akira","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-6087","authenticated-orcid":false,"given":"Hisatoshi","family":"Ishikura","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-6345","authenticated-orcid":false,"given":"Takeyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-3930","authenticated-orcid":false,"given":"Taku","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-9414","authenticated-orcid":false,"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-469X","authenticated-orcid":false,"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo , Tokyo 113-0033 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2026082014415794800_ref1"},{"issue":"8","key":"2026082014415794800_ref2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrrheum.2013.113","article-title":"Osteoarthritis: osteoporotic OA: a reasonable target for bone-acting agents","volume":"9","author":"Herrero-Beaumont","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"2026082014415794800_ref3","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/biomedicines12102292","article-title":"The pathogenetic role of RANK\/RANKL\/OPG Signaling in osteoarthritis and related targeted therapies","volume":"12","author":"Di Cicco","year":"2024","journal-title":"Biomedicines"},{"issue":"10","key":"2026082014415794800_ref4","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"issue":"10","key":"2026082014415794800_ref5","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","article-title":"Goal-directed osteoporosis treatment: ASBMR\/BHOF Task Force Position Statement 2024","volume":"39","author":"Cosman","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026082014415794800_ref6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"2026082014415794800_ref7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jos.2024.01.011","article-title":"Anti-osteoporotic drug efficacy for periprosthetic bone loss after total hip arthroplasty: a systematic review and network meta-analysis","volume":"30","author":"Hatano","year":"2025","journal-title":"J Orthop Sci"},{"key":"2026082014415794800_ref8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.reth.2024.03.019","article-title":"Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling","volume":"27","author":"Shangguan","year":"2024","journal-title":"Regen Ther"},{"issue":"3","key":"2026082014415794800_ref9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41591-024-02822-0","article-title":"RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2A trial","volume":"30","author":"Wittoek","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"2026082014415794800_ref10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.31662\/jmaj.2021-0189","article-title":"Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people","volume":"5","author":"Okada","year":"2022","journal-title":"JMA J"},{"issue":"8","key":"2026082014415794800_ref11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2026082014415794800_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-026-06897-x","article-title":"Improving the design of observational studies in orthopaedics: a practical guide to target trial emulation","author":"Hatano","year":"2026","journal-title":"Int Orthop"},{"issue":"2","key":"2026082014415794800_ref13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.joca.2017.11.013","article-title":"Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials","volume":"26","author":"Vaysbrot","year":"2018","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"2026082014415794800_ref14","doi-asserted-by":"publisher","first-page":"e006832","DOI":"10.1136\/rmdopen-2026-006832","article-title":"Oral bisphosphonates and risk of incident osteoarthritis in individuals with osteoporosis: a target trial emulation","volume":"12","author":"Hatano","year":"2026","journal-title":"RMD Open"},{"issue":"11","key":"2026082014415794800_ref15","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.ard.2025.06.2124","article-title":"Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: a target trial emulation study","volume":"84","author":"Hatano","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2026082014415794800_ref16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"11","key":"2026082014415794800_ref17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"3","key":"2026082014415794800_ref18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2188\/jea.JE20220310","article-title":"Claims-based frailty index in Japanese older adults: a cohort study using LIFE study data","volume":"34","author":"Nakatsuka","year":"2024","journal-title":"J Epidemiol"},{"issue":"9","key":"2026082014415794800_ref19","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1136\/annrheumdis-2013-203355","article-title":"Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints","volume":"73","author":"Prieto-Alhambra","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2026082014415794800_ref20","doi-asserted-by":"publisher","first-page":"e179942","DOI":"10.1172\/jci179942","article-title":"Bisphosphonates for osteoporosis: from bench to clinic","volume":"134","author":"Bellido","year":"2024","journal-title":"J Clin Invest"},{"key":"2026082014415794800_ref21","doi-asserted-by":"publisher","first-page":"101090","DOI":"10.1016\/j.bonr.2021.101090","article-title":"Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: a prospective cohort study","volume":"14","author":"Tsuchiya","year":"2021","journal-title":"Bone Rep"},{"issue":"1","key":"2026082014415794800_ref22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11657-017-0371-y","article-title":"Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis: denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis","volume":"12","author":"Nakamura","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"12","key":"2026082014415794800_ref23","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/life14121704","article-title":"Incidence of total knee arthroplasty in older females with knee osteoarthritis and osteoporosis treated with denosumab compared with those treated using bisphosphonates: a population-based cohort study","volume":"14","author":"Yu","year":"2024","journal-title":"Life (Basel)"},{"issue":"10","key":"2026082014415794800_ref24","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s10067-017-3681-y","article-title":"Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-the ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation)","volume":"36","author":"Saviola","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2026082014415794800_ref25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10165-011-0506-8","article-title":"Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study","volume":"22","author":"Saviola","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"4","key":"2026082014415794800_ref26","doi-asserted-by":"publisher","first-page":"R152","DOI":"10.1186\/ar3103","article-title":"Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis","volume":"12","author":"Bellido","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2026082014415794800_ref27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/art.27204","article-title":"Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis","volume":"62","author":"Moreno-Rubio","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2026082014415794800_ref28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/acr.24861","article-title":"Incidence and prevalence of knee osteoarthritis using codified and narrative data from electronic health records: a population-based study","volume":"74","author":"Arslan","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag113\/69802345\/zjag113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag113\/69802345\/zjag113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:42:06Z","timestamp":1787251326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article\/doi\/10.1093\/jbmr\/zjag113\/8740008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag113","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"zjag113"}}